ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012